follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeHealthBiotechnology

      Biotechnology

      The biotechnology sector focuses on developing drugs predominantly for the Healthcare sector. 

      These companies make products from living organisms such as plant life and,  through biotechnology, are developing treatment or cures for a specific ailment.

      Examples of biotechnology companies include AVEO, Aeterna Zentaris, and Sorrento Therapeutics.

      INSY Stock
      Biotechnology

      INSY Stock Hits All-Time Low On Bankruptcy’s News

      May 13 Ankit Singhania
      INSY stock is having the worst day after Insys Therapeutics Inc. (NASDAQ:INSY)’s warning that the company was seeking bankruptcy protection after losing millions of dollars in legal payments. Chapter 11 Expected  On Friday after the market ... [Read]
      PBYI stock
      Biotechnology

      PBYI Stock Nosedives: Puma Biotechnology’s Nerlynx Revenue Falls

      May 10 Ankit Singhania
      PBYI stock is the biggest loser in the biotech sector after Puma Biotechnology Inc. (NASDAQ:PBYI) reported disappointing revenue for its only commercial product, Nerlynx. Nevertheless, the company posted improved loss and revenue for the fiscal ... [Read]
      BioTime Stock
      Biotechnology

      BioTime Stock: “Buy” Ratings Abound, Should You Take Note?

      May 8 Maria Ohle
      BioTime stock is currently selling for $1.18 USD on the NYSE American exchange. At the time of writing, shares are down nearly 5%. Despite a rough few trading days, BTX stock has a consensus rating ... [Read]
      Biotech Stocks
      Biotechnology

      Biotech Stocks Hitting the Public Market This Year: Best Ones to Watch

      May 3 Kristen Moran
      Last year was a record year for biotech stocks, with an impressive number of companies going public and raising a significant amount of money in the space. In fact, in 2018 there were 80 biotech ... [Read]
      ABIO Stock
      Biotechnology

      ABIO Stock Gets Attention: Are You Watching ARCA Biopharma?

      May 3 Ankit Singhania
      ABIO stock has been on fire over the past two trading sessions, with a huge jump of 150%. As far as biopharmaceutical companies are concerned, positive news of some variety can often send the stock ... [Read]
      ARQL stock
      Biotechnology

      ARQL Stock Doubles in 2 Months: What to Do with ArQule Now?

      May 2 Ankit Singhania
      ARQL stock is on fire this year, and much of those gains are due to ArQule Inc’s (NASDAQ:ARQL) handsome cash balance and developments that bode well for its flagship drug, ARQ 531. The Burlington, Massachusetts-based ... [Read]
      ADMA Stock
      Biotechnology

      ADMA Stock Receives Consensus “Buy” Rating, Major Upswing Ahead?

      May 1 Maria Ohle
      ADMA stock has just received a consensus rating of “Buy” from nine brokerages covering the stock. With all in agreement, why are analysts bullish on this biotechnology stock? Let’s find out! AMDA Stock Selling for ... [Read]
      AXSM stock
      Biotechnology

      AXSM Stock Climbs 550%: Key Drivers Investors Should Be Looking For

      Apr 29 Ankit Singhania
      Little known biopharmaceutical AXSM stock has been on a tear, and the stock has jumped by a staggering 550% as big news regarding one of the Axsome Therapeutics Inc’s (NASDAQ:AXSM) drugs proved decisive for many ... [Read]
      IPATF stock
      Biotechnology

      IPATF Stock Soars: Subsidiary Receives Exclusive License from Stanford

      Apr 26 Caroline Harris
      On Friday, April 26, ImmunoPrecise Antibodies’ subsidiary U-Protein Express disclosed that it’s obtained an exclusive license from Stanford University. The license allows U-Protein Express to manufacture and sell Wnt surrogate Fc. On the news, IPATF ... [Read]
      Biotechnology

      ImmunoPrecise Antibodies’ Subsidiary U-Protein Express Announces Exclusive Agreement as Global Supplier for Wnt-Surrogate-Fc Growth Factor

      Apr 25 microsmallcap
      VICTORIA, April 25, 2019 /CNW/ – ImmunoPrecise Antibodies Ltd.(TSX:IPA)(OTC:IPATF)(FRA: TQB2)(the “Company” or “IPA”) U-Protein Express, a wholly-owned ImmunoPrecise Antibodies subsidiary, in Utrech, Netherlands, announced that it has obtained an exclusive license from Stanford University to ... [Read]

      Posts pagination

      « 1 … 14 15 16 … 32 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767